May 2 (Reuters) - Biophytis SA ALBPS.PA :
* ANNOUNCED ON FRIDAY THAT IT HAS RECEIVED WRITTEN
NOTIFICATION
FROM NASDAQ STOCK MARKET LLC DATED APRIL 24, 2023, INDICATING
THAT, BASED ON REPORTED STOCKHOLDERS’ EQUITY OF (€1,911,000) OF
BIOPHYTIS AS REPORTED IN ITS 20-F, COMPANY DOES NOT MEET MINIMUM
SHAREHOLDERS’ EQUITY CRITERIA OF $2,500,000 IN STOCKHOLDERS’
EQUITY FOR CONTINUED LISTING
* NOTIFICATION LETTER HAS NO IMMEDIATE EFFECT ON LISTING OF
ADSS,
AND THEY WILL CONTINUE TO TRADE ON THE NASDAQ GLOBAL SELECT
MARKET UNDER THE SYMBOL “BPTS”
* BIOPHYTIS HAS 45 CALENDAR DAYS, OR UNTIL JUNE 8, 2023, TO
SUBMIT
A PLAN TO REGAIN COMPLIANCE
* IF THE PLAN IS ACCEPTED, NASDAQ CAN GRANT AN EXTENSION OF
UP TO
180 CALENDAR DAYS FROM THE DATE OF THE NASDAQ LETTER TO EVIDENCE
COMPLIANCE
* INTENDS TO REGAIN COMPLIANCE WITHIN THE APPLICABLE
COMPLIANCE
PERIOD AND IS CURRENTLY WORKING ON A PLAN INCLUDING FINANCIAL
AND SCIENTIFIC PROJECTIONS
Source text for Eikon: urn:newsml:reuters.com:*:nEQ2t4LS8a
Further company coverage: ALBPS.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))